SCHEMBL1622357

SCHEMBL1622357

N#CCS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073653 0.72
SCHEMBL1896274 0.69
SCHEMBL465592 0.69
SCHEMBL19661004 0.69
SCHEMBL3986656 0.69
SCHEMBL15434587 0.67
SCHEMBL6970625 0.67
SCHEMBL19660934 0.67
SCHEMBL1896275 0.67
SCHEMBL12847695 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12320012-B2 Thermal atomic layer etching processes ASM IP HOLDING B.V. (NL) 2025-06-03 US claimed
US-20230374671-A1 THERMAL ATOMIC LAYER ETCHING PROCESSES ASM IP HOLDING B.V. (NL) 2023-11-23 US claimed
CN-122031506-A Chiral control 波涛生命科学有限公司 2026-05-15 CN disclosed
CN-122051376-A Sulfinate electrolyte additive for lithium secondary battery and nonaqueous electrolyte 浙江永太新能源材料有限公司 2026-05-15 CN disclosed
EP-4741018-A2 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-05-13 EP disclosed
US-20260125379-A1 PRODRUG OF JAK KINASE INHIBITOR E NITIATE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN) 2026-05-07 US disclosed
US-20260116881-A1 KIF MODULATOR COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-20260092053-A1 KHK INHIBITORS GILEAD SCIENCES INC (US) 2026-04-02 US disclosed
EP-3912979-B1 TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2026-03-25 EP disclosed
US-12583836-B2 Sulphonamide compounds Anaxis Pharma Pty Ltd (AU) 2026-03-24 US disclosed
EP-4701735-A1 HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR Nested Therapeutics, Inc. (US) 2026-03-04 EP disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed
US-5559081-A Sulfonamide herbicides AGREVO UK LIMITED (GB) 1996-09-24 US disclosed
WO-1995024190-A2 RECEPTOR TYROSINE KINASE INHIBITORS FOR INHIBITING CELL PROLIFERATIVE DISORDERS AND COMPOSITIONS THEREOF SUGEN, INC. (US) 1995-09-14 WO disclosed
EP-0625970-A1 SULFONAMIDE HERBICIDES. AGREVO UK LTD (GB) 1994-11-30 EP disclosed
WO-1993009099-A2 SULFONAMIDE HERBICIDES AGREVO UK LIMITED (GB) 1993-05-13 WO disclosed
US-4578469-A COUMARIN DYES HOECHST AKTIENGESELLSCHAFT (DE) 1986-03-25 US disclosed
US-4107304-A Oxo-imidazolidine substituted cephalosporins and antibacterial compositions and methods of combatting bacteria employing them BAYER AKTIENGESELLSCHAFT (DE) 1978-08-15 US disclosed
US-4093722-A ANTIBIOTICS BAYER AKTIENGESELLSCHAFT (DT) 1978-06-06 US disclosed
US-4086340-A ANTIBIOTIC; ANIMAL GROWTH PROMOTER BAYER AKTIENGESELLSCHAFT (DT) 1978-04-25 US disclosed